| Year |
Citation |
Score |
| 2019 |
An P, Kirk GD, Limou S, Binns-Roemer E, Kopp JB, Winkler CA. Impact of Genetic Variants on HIV-1 Infection and Disease Progression. Frontiers in Immunology. 10: 53. PMID 30733721 DOI: 10.3389/Fimmu.2019.00053 |
0.304 |
|
| 2017 |
Kirk GD, Dandorf S, Li H, Chen Y, Mehta SH, Piggott DA, Margolick JB, Leng SX. Differential Relationships among Circulating Inflammatory and Immune Activation Biomediators and Impact of Aging and Human Immunodeficiency Virus Infection in a Cohort of Injection Drug Users. Frontiers in Immunology. 8: 1343. PMID 29097998 DOI: 10.3389/Fimmu.2017.01343 |
0.32 |
|
| 2014 |
Etemad B, Gonzalez OA, White L, Laeyendecker O, Kirk GD, Mehta S, Sagar M. Characterization of HIV-1 envelopes in acutely and chronically infected injection drug users. Retrovirology. 11: 106. PMID 25430652 DOI: 10.1186/s12977-014-0106-8 |
0.31 |
|
| 2013 |
Kirk GD, Mehta SH, Astemborski J, Galai N, Washington J, Higgins Y, Balagopal A, Thomas DL. HIV, age, and the severity of hepatitis C virus-related liver disease: a cohort study. Annals of Internal Medicine. 158: 658-66. PMID 23440167 DOI: 10.7326/0003-4819-158-9-201305070-00604 |
0.301 |
|
| 2013 |
Hanna DB, Buchacz K, Gebo KA, Hessol NA, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, Korthuis PT, Moore RD, Napravnik S, Patel P, Silverberg MJ, Sterling TR, Willig JH, et al. Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 56: 1174-82. PMID 23315317 DOI: 10.1093/Cid/Cit003 |
0.304 |
|
| 2012 |
Drummond MB, Kirk GD, Astemborski J, Marshall MM, Mehta SH, McDyer JF, Brown RH, Wise RA, Merlo CA. Association between obstructive lung disease and markers of HIV infection in a high-risk cohort. Thorax. 67: 309-14. PMID 22090038 DOI: 10.1136/Thoraxjnl-2011-200702 |
0.302 |
|
| 2011 |
Salter ML, Lau B, Go VF, Mehta SH, Kirk GD. HIV infection, immune suppression, and uncontrolled viremia are associated with increased multimorbidity among aging injection drug users. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 53: 1256-64. PMID 21976463 DOI: 10.1093/Cid/Cir673 |
0.33 |
|
| 2011 |
Stabinski L, Reynolds SJ, Ocama P, Laeyendecker O, Ndyanabo A, Kiggundu V, Boaz I, Gray RH, Wawer M, Thio C, Thomas DL, Quinn TC, Kirk GD. High prevalence of liver fibrosis associated with HIV infection: a study in rural Rakai, Uganda. Antiviral Therapy. 16: 405-11. PMID 21555823 DOI: 10.3851/Imp1783 |
0.301 |
|
| 2011 |
Stabinski L, Reynolds SJ, Ocama P, Laeyendecker O, Serwadda D, Gray RH, Wawer M, Thomas DL, Quinn TC, Kirk GD. Hepatitis B virus and sexual behavior in Rakai, Uganda. Journal of Medical Virology. 83: 796-800. PMID 21412787 DOI: 10.1002/Jmv.22051 |
0.302 |
|
| 2007 |
Kirk GD, Vlahov D. Improving survival among HIV-infected injection drug users: how should we define success? Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 45: 377-80. PMID 17599318 DOI: 10.1086/519426 |
0.304 |
|
| 1982 |
Kirk G, Gruner S. Encapsulated scintillators monitor 3h-solute concentrations Ieee Transactions On Nuclear Science. 29: 769-772. DOI: 10.1109/Tns.1982.4335954 |
0.362 |
|
| Show low-probability matches. |